Baxter International Inc.
General ticker "BAX" information:
- Sector: Health Care
- Industry: Medical - Instruments & Supplies
- Capitalization: $14.5B (TTM average)
Baxter International Inc. does not follow the US Stock Market performance with the rate: -20.9%.
Estimated limits based on current volatility of 1.4%: low 18.62$, high 19.13$
Factors to consider:
- Company included in S&P500 list
- Company pays dividends (quarterly): last record date 2026-02-27, amount 0.01$ (Y0.22%)
- Total employees count: 38000 (-36.7%) as of 2024
- US accounted for 0.3% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Liquidity and credit risks, Strategic risks and growth management, Manufacturing disruptions, Cybersecurity threats, Reputation and brand risks
- Price in estimated range
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [13.04$, 25.84$]
- 2026-12-31 to 2027-12-31 estimated range: [14.69$, 27.63$]
Financial Metrics affecting the BAX estimates:
- Positive: with PPE of 8.4 at the end of fiscal year the price was neutral
- Positive: -4.75 < Operating profit margin, % of -2.67
- Positive: 6.64 < Operating cash flow per share per price, % of 8.61
- Negative: negative Net income
- Negative: Industry earnings per price (median), % of 0 <= 0
- Positive: 19.40 < Shareholder equity ratio, % of 30.56 <= 42.68
- Negative: Industry operating cash flow per share per price (median), % of 1.99 <= 5.46
- Positive: -9.07 < Industry operating profit margin (median), % of -2.56
Short-term BAX quotes
Relationship graph
Long-term BAX plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $10,388.00MM | $10,648.00MM | $11,244.00MM |
| Operating Expenses | $9,681.00MM | $10,634.00MM | $11,552.00MM |
| Operating Income | $707.00MM | $14.00MM | $-308.00MM |
| Non-Operating Income | $-465.00MM | $-303.00MM | $-197.00MM |
| Interest Expense | $439.00MM | $341.00MM | $290.00MM |
| R&D Expense | $518.00MM | $590.00MM | $518.00MM |
| Income(Loss) | $242.00MM | $-289.00MM | $-505.00MM |
| Taxes | $61.00MM | $37.00MM | $395.00MM |
| Other Income(Loss) | $2,482.00MM | $-312.00MM | $0.00MM |
| Profit(Loss)* | $2,656.00MM | $-649.00MM | $-900.00MM |
| Stockholders Equity | $8,402.00MM | $6,964.00MM | $6,129.00MM |
| Inventory | $1,918.00MM | $2,046.00MM | $2,232.00MM |
| Assets | $28,276.00MM | $25,782.00MM | $20,055.00MM |
| Operating Cash Flow | $1,726.00MM | $1,019.00MM | $845.00MM |
| Capital expenditure | $436.00MM | $460.00MM | $522.00MM |
| Investing Cash Flow | $3,213.00MM | $-626.00MM | $2,841.00MM |
| Financing Cash Flow | $-3,489.00MM | $-1,081.00MM | $-4,216.00MM |
| Earnings Per Share** | $5.25 | $-1.27 | $-1.75 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.